Dmitry Balyasny’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.6M Buy
+1,266,091
New +$23.8M 0.02% 760
2026
Q1
– Sell
-262,788
Closed -$5.78M – 3531
2025
Q4
$5.78M Buy
+262,788
New +$4.74M 0.01% 1322
2025
Q3
– Sell
-230,934
Closed -$4.3M – 3476
2025
Q2
$4.3M Sell
230,934
-538,809
-70% -$10.7M 0.01% 1362
2025
Q1
$14.7M Buy
+769,743
New +$22.5M 0.02% 726
2024
Q3
– Sell
-8,629
Closed -$348K – 3171
2024
Q2
$348K Sell
8,629
-225,891
-96% -$9.42M ﹤0.01% 2183
2024
Q1
$8.3M Buy
234,520
+128,111
+120% +$3.43M 0.01% 1008
2023
Q4
$3.15M Buy
+106,409
New +$2.21M 0.01% 1298
2023
Q2
– Sell
-280,192
Closed -$11.4M – 2790
2023
Q1
$11.4M Sell
280,192
-300,703
-52% -$12.4M 0.03% 728
2022
Q4
$26.1M Buy
580,895
+287,375
+98% +$13M 0.07% 370
2022
Q3
$14M Buy
+293,520
New +$16.1M 0.04% 548
2022
Q2
– Sell
-102,891
Closed -$12M – 3184
2022
Q1
$12M Sell
102,891
-68,587
-40% -$8.01M 0.04% 629
2021
Q4
$25.8M Buy
+171,478
New +$23.1M 0.09% 313
2020
Q4
– Sell
-285,720
Closed -$32.4M – 1699
2020
Q3
$32.4M Buy
285,720
+131,026
+85% +$13.8M 0.24% 104
2020
Q2
$15.3M Sell
154,694
-2,849
-2% -$227K 0.13% 236
2020
Q1
$10.1M Sell
157,543
-251,471
-61% -$17.6M 0.12% 227
2019
Q4
$24.4M Buy
409,014
+191,161
+88% +$11.8M 0.15% 214
2019
Q3
$12.8M Sell
217,853
-39,240
-15% -$2.5M 0.09% 338
2019
Q2
$16.6M Buy
257,093
+252,928
+6,073% +$16.3M 0.11% 263
2019
Q1
$264K Sell
4,165
-82,270
-95% -$4.32M ﹤0.01% 1319
2018
Q4
$3.28M Buy
86,435
+27,462
+47% +$970K 0.02% 588
2018
Q3
$2.53M Sell
58,973
-356,027
-86% -$12.4M 0.01% 912
2018
Q2
$9.14M Buy
415,000
+127,500
+44% +$1.57M 0.04% 512
2018
Q1
$1.43M Buy
+287,500
New +$927K 0.01% 1097

Other funds holding TNDM

Dmitry Balyasny's TNDM Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Tandem Diabetes Care (TNDM) in Q3 2026: 1,266,091 shares worth $20.6M. The stake represents 0.02% of the portfolio and ranks #760 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in TNDM as recently as Q4 2025.

Dmitry Balyasny first reported a position in TNDM in Q1 2018 and has held it in 23 quarters since. The position peaked at $32.4M in Q3 2020. 267 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Dmitry Balyasny held 1,266,091 shares of Tandem Diabetes Care worth $20.6M as of Q3 2026.
  • Tandem Diabetes Care was a new Dmitry Balyasny position in Q3 2026.
  • Tandem Diabetes Care made up 0.02% of Dmitry Balyasny's portfolio in Q3 2026, its #760 holding.
  • Dmitry Balyasny first reported a position in Tandem Diabetes Care in Q1 2018 and has held it in 23 quarters since.
  • Dmitry Balyasny's Tandem Diabetes Care position peaked at $32.4M in Q3 2020.
  • 267 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.